Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects
Public ClinicalTrials.gov record NCT01994109. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC® Followed by Open-Label, Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects
Study identification
- NCT ID
- NCT01994109
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
- Industry
- Enrollment
- 187 participants
Conditions and interventions
Conditions
Interventions
- MYOBLOC Drug
- PLACEBO Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2013
- Primary completion
- Dec 31, 2015
- Completion
- Dec 31, 2016
- Last update posted
- Apr 20, 2026
2013 – 2017
United States locations
- U.S. sites
- 24
- U.S. states
- 17
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Loma Linda | California | 92354 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | National City | California | 91950 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Washington D.C. | District of Columbia | 20007 | — |
| Not listed | Boca Raton | Florida | 33486 | — |
| Not listed | Port Charlotte | Florida | 33980 | — |
| Not listed | Carmel | Indiana | 46032 | — |
| Not listed | Baltimore | Maryland | 21287 | — |
| Not listed | Elkridge | Maryland | 21075 | — |
| Not listed | Detroit | Michigan | 48334 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Edison | New Jersey | 08818 | — |
| Not listed | Albany | New York | 12208 | — |
| Not listed | New York | New York | 10003 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Tulsa | Oklahoma | 74136 | — |
| Not listed | Port Royal | South Carolina | 29935 | — |
| Not listed | Cordova | Tennessee | 38018 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
| Not listed | Kirkland | Washington | 98034 | — |
| Not listed | Tacoma | Washington | 98409 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01994109, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2026 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01994109 live on ClinicalTrials.gov.